Results 91 to 100 of about 31,072 (141)

Erythroderma, Alopecia, Anhidrosis, and Vitiligo as Complications of a Red Ink Tattoo—A Case Report

Clinics and Practice
Background: Adverse reactions to tattoo pigments are increasingly recognized, yet severe systemic complications remain rare and poorly characterized. Red tattoo ink, in particular, is associated with delayed hypersensitivity reactions, but widespread ...
Mateusz K. Mateuszczyk, Magdalena Łyko, Andrzej Bieniek, Joanna Maj, Alina Jankowska-Konsur   +4 more
doaj   +1 more source

A rare case of alopecia universalis. [PDF]

Pan Afr Med J, 2023
Deshpande A, Deshpande M.
europepmc   +1 more source

Autoimmune Polyglandular Syndrome Type 2 Presentation with Alopecia Universalis, Hashimoto’s Disease, and Addison’s Disease

International Medical Case Reports Journal
Karla Denisse Sales-Morales,1,* Nazhira Torres-Neme,2 Vladimir Barrera-Villanueva,3 Alejandro Martínez-Carreón1,* 1Department of Internal Medicine, High Specialty Regional Hospital, ISSSTE, Veracruz, Mexico; 2Department of Endocrinology ...
Sales-Morales KD, Torres-Neme N, Barrera-Villanueva V, Martínez-Carreón A   +3 more
doaj  

Alopecia areata universalis during off-label treatment with Infliximab in a patient with Behçet disease

, 2010
Infliximab, a chimeric monoclonal anti-TNF-alfa agent used to treat autoimmune diseases, has shown a paradoxical side effect in the development of autoimmunity.
Fabbri P., Emmi L., Squatrito D., Beccastrini E., Emmi G.   +4 more
core  

Diphenylcyclopropenone in severe alopecia areata in children and adolescents: long-term follow-up and relapse rate

Journal of the Egyptian Women’s Dermatologic Society
Background Reports on the long-term treatment of alopecia areata (AA) in children with diphenylcyclopropenone (DPCP) are few. Objective To assess response, side effects, and relapse rates during long-term follow-up in children with severe AA treated with
Yasmin B. El Zawahry, Bakr M. El Zawahry, Dalia A. Bassiouny, Ahmed M. Soliman, Heba M. Abdel-Raheem   +4 more
doaj   +1 more source

Clobetasol propionate 0.05% under occlusion in the treatment of alopecia totalis/universalis

, 2003
Background: Efficacy of topical steroids in alopecia areata is still discussed. Objective: The purpose of this study was to evaluate the efficacy of clobetasol propionate 0.05% ointment under occlusion in 28 patients with alopecia areata totalis (AT) or ...
Tosti A., Vincenzi C., Piraccini B. M., Pazzaglia M.   +3 more
core   +1 more source

Reversible alopecia universalis secondary to PEG-interferon alpha-2b and ribavirin combination therapy in a patient with chronic hepatitis C virus infection

, 2007
Combined treatment with pegylated interferon (PEG-IFN) and ribavirin is currently recommended for the treatment of chronic hepatitis C virus (HCV) infection.
Ozgunes, Ilhan, NAYMAN ALPAT, SAYGIN, DOYUK KARTAL, ELİF, USLUER, GAYE   +3 more
core   +1 more source

Effective treatment of alopecia universalis with oral upadacitinib. [PDF]

JAAD Case Rep, 2023
Youssef S, Bordone LA.
europepmc   +1 more source

Viral-Induced Rapidly Progressive Alopecia Universalis: A Case Report and Literature Review. [PDF]

Cureus, 2023
Alotaibi MA, Altaymani A, Al-Omair A, Alghamdi W.   +3 more
europepmc   +1 more source

Upadacitinib for Successful Treatment of Alopecia Universalis in a Child: A Case Report and Literature Review. [PDF]

Acta Derm Venereol, 2023
Yu D, Ren Y.
europepmc   +1 more source